News
Australian Listed Medicine brand Pure Australia expands global portfolio through LDV20 and NYXIS Australian wellness company Pure Australia, operating under the brand OZNEX, is accelerating its international expansion strategy with LDV20 as its core flagship product. LDV20 serves as the...
Continue reading
Quick Summary OZNEX is an Australian wellness company operated by Pure Australia.Its flagship product NYXIS is an Australian Listed Medicine (AUST L 470386) manufactured under TGA regulation in Australia.NYXIS has been launched on Air Seoul inflight duty free as part...
Continue reading
MEDIA COVERAGE · PRODUCT FEATURE Summary: Korean online media has highlighted LDV20, manufactured by Pure Australia, as a product gaining attention in the Korean market for its four-ingredient complex formulation design. The article reflects a shift in consumer behaviour —...
Continue reading
BRAND ANNOUNCEMENT · CORPORATE RESPONSIBILITY Summary: Pure Australia has been officially recognised as a Major Sponsor of the Stroke Foundation, Australia's leading national stroke advocacy organisation. This milestone reflects Pure Australia's long-term commitment to public health awareness and to supporting...
Continue reading
MEDIA COVERAGE · BRAND NEWS Summary: Pure Australia has been named the Exclusive Sponsor of the Creative Award at the 2026 National Stroke Awards, hosted by Australia's Stroke Foundation. Featuring our flagship LDV20 brand — a TGA Listed Medicine (AUST...
Continue reading